Edwards Lifesciences Corp. closed 28.34% below its 52-week high of $95.25, which the company achieved on July 11th.

Edwards Lifesciences Corporation (EW), a $39.4 billion medical technology firm based in Irvine, California, specializes in ...

Ben McCullough met the 25 Edwards Lifesciences technicians who spent 20 hours hand-sewing 2,000 stitches to make a valve ...

New appointees with Edwards Lifesciences, with Laya Healthcare, Kepak Group, Allianz, Cullen Communications and Ringers ...

Ben McCullough, 76, received an EVOQUE heart valve last fall. On Wednesday, he got to thank the makers face-to-face.

The court announcing it will follow the EPO on inventive step, a case with a Chinese element, and three big settlements were ...

Results from the EARLY TAVR trial — the first randomized, controlled FDA pivotal study designed to determine the best ...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Edwards Lifesciences recently announced significant findings at the ACC Annual Scientific Session, showcasing crucial research in the treatment of structural heart disease. This development ...

Shares of Edwards Lifesciences Corp. EW shed 2.80% to $67.07 Tuesday, on what proved to be an all-around dismal trading ...